Rubicon Organics Inc. (TSXV: ROMJ)
Health Care · Pharmaceuticals · CA
CA$0.45
+2.27% today · -22.4% 1Y
Rubicon Organics Inc. (TSXV: ROMJ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $21.31M and employs 265 people.
Over the last twelve months the share price has lost 22.4%, trading between 0.37 and 0.65.
Tweenvest scores Rubicon Organics Inc. across four factors: quality 56/100, value 79/100, growth 87/100. Its strongest factor is growth.
ROMJ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.31M
- Revenue (TTM)
- $45.23M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- CA$0.65
- 52-week low
- CA$0.37
- Avg volume (3M)
- —
- Shares outstanding
- 67.58M
- Employees
- 265
- Next earnings
- —
About Rubicon Organics Inc.
Rubicon Organics Inc. cultivates, processes, and distributes organic cannabis products for both recreational and medicinal consumers across Canada. The company markets its organic cannabis through its proprietary labels as well as various licensed brands. Founded in 2015, Rubicon Organics Inc. maintains its headquarters in Vancouver, Canada.
- ISIN
- CA78112W1005
- Founded
- 2015
- Listed since
- Oct 10, 2018
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aytu BioPharma, Inc.NasdaqCM: AYTU | $22.01M | $2.02 | -0.25% |
| Accretion Pharmaceuticals LimitedNSEI: ACCPL | $21.70M | Rs188.95 | -7.06% |
| Accretion Nutraveda LimitedBSE: 544694 | $21.69M | Rs290.00 | -4.92% |
| Public Joint-Stock Company "Pharmsynthez"MISX: LIFE | $21.52M | RUB— | — |
| Philadelphia Pharmaceuticals CompanyASE: PHIL | $21.16M | JD2.00 | +5.26% |
| Coral Laboratories LimitedBSE: 524506 | $21.12M | Rs572.25 | +4.31% |
| MediPharm Labs Corp.TSX: LABS | $20.96M | CA$0.07 | 0.00% |
| Universe Pharmaceuticals INCNasdaqCM: UPC | $20.85M | $4.13 | -0.48% |
Figures last refreshed Oct 11, 2026.